Han Liang Selected Research

Han Liang Research Topics

Disease

150	Neoplasms (Cancer) 03/2022 - 01/2002
110	Stomach Neoplasms (Stomach Cancer) 06/2022 - 04/2003
45	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2006
30	Lymphatic Metastasis 11/2021 - 01/2002
13	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
10	Carcinoma (Carcinomatosis) 01/2021 - 08/2004
7	Carcinogenesis 12/2021 - 10/2013
6	Adenocarcinoma 04/2021 - 01/2002
5	Colonic Neoplasms (Colon Cancer) 01/2014 - 08/2004
4	Endometrial Neoplasms (Endometrial Cancer) 08/2017 - 07/2011
3	Triple Negative Breast Neoplasms 01/2022 - 02/2016
3	Infections 01/2022 - 05/2012
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2015
3	Leukemia 05/2018 - 01/2015
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2014 - 06/2012
3	Hyperthermia 05/2008 - 08/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 02/2020 - 04/2003
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 10/2017
2	Lung Neoplasms (Lung Cancer) 08/2019 - 01/2019
2	Genomic Instability 08/2019 - 05/2015
2	Hypoxia (Hypoxemia) 01/2019 - 01/2013
2	Lymphoma (Lymphomas) 04/2018 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 08/2017
2	Disease Progression 11/2017 - 06/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 01/2016
2	Peritoneal Neoplasms 01/2016 - 04/2003
2	Inflammation (Inflammations) 04/2015 - 02/2013
2	Hemorrhage 02/2013 - 03/2012
2	Rectal Neoplasms (Rectal Cancer) 08/2007 - 01/2002

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2010
19	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2012
18	Messenger RNA (mRNA)IBA 11/2020 - 11/2010
16	RNA (Ribonucleic Acid)IBA 11/2021 - 05/2012
15	Pharmaceutical PreparationsIBA 03/2022 - 09/2015
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
12	Biological ProductsIBA 01/2021 - 09/2007
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
8	ProteomeIBA 01/2022 - 05/2014
8	Long Noncoding RNAIBA 12/2018 - 09/2015
7	immune RNA (I-RNA)IBA 01/2022 - 10/2015
5	Phosphotransferases (Kinase)IBA 01/2022 - 10/2012
5	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2012
5	Indicators and Reagents (Reagents)IBA 02/2015 - 11/2009
4	NucleotidesIBA 12/2019 - 01/2018
4	hydrogen sulfite (bisulfite)IBA 01/2015 - 01/2014
4	Cadherins (E-Cadherin)IBA 03/2014 - 08/2004
3	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2014
3	AntigensIBA 01/2020 - 01/2018
3	CateninsIBA 01/2020 - 03/2014
3	Inosine FDA Link 01/2018 - 10/2015
3	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 10/2015
3	Imatinib Mesylate (Gleevec)FDA Link 11/2017 - 06/2012
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 08/2011
2	Amino Acids FDA Link 01/2022 - 10/2018
2	SaltsIBA 01/2022 - 12/2015
2	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2014
2	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2014
2	EnzymesIBA 03/2020 - 01/2020
2	AntibodiesIBA 01/2020 - 05/2014
2	ChromatinIBA 01/2020 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 12/2017
2	Tyrosine Kinase InhibitorsIBA 05/2018 - 04/2014
2	Histone MethyltransferasesIBA 04/2018 - 04/2015
2	Deubiquitinating EnzymesIBA 04/2018 - 01/2018
2	Serum AlbuminIBA 01/2018 - 02/2011
2	UbiquitinIBA 01/2018 - 12/2017
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 04/2014
2	TeaIBA 12/2015 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 11/2015 - 12/2010
2	SolutionsIBA 04/2015 - 04/2003
2	LigandsIBA 01/2015 - 11/2009
2	Vascular Endothelial Growth Factor DIBA 01/2014 - 11/2009
2	CytokinesIBA 12/2013 - 11/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2012 - 07/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2007 - 04/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	Cyclic PeptidesIBA 01/2022
1	VaccinesIBA 01/2022

Therapy/Procedure

62	Gastrectomy 07/2021 - 11/2007
40	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 07/2007
33	Therapeutics 06/2022 - 01/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
7	Immunotherapy 01/2021 - 08/2017
5	Adjuvant Chemotherapy 01/2021 - 09/2007
4	Operative Surgical Procedures 05/2018 - 10/2010
3	Neoadjuvant Therapy 01/2021 - 01/2020
3	Hyperthermic Intraperitoneal Chemotherapy 12/2020 - 02/2012
3	Length of Stay 12/2020 - 06/2011
3	Cytoreduction Surgical Procedures 08/2016 - 02/2010
3	Blood Transfusion (Blood Transfusions) 01/2016 - 03/2006
2	Operative Time 03/2013 - 06/2011
2	Aftercare (After-Treatment) 05/2008 - 08/2007
2	Radiotherapy 05/2008 - 08/2007
1	Fecal Microbiota Transplantation 01/2022